Chinese
Home
About Livzon
Milestones
Leaders' Caring
Company Honors
Cultural Vision
Contact Us
Media
Livzon News
Employment system
Investor Relations
Company Governance
Announcement
Financial Reports
ESG Report
Shareholder Returns
Stock Information
Sustainable Development
Human Development
Board Diversity Policy
Business Ethics
Supplier
Environment, Occupational Health and Safety (EHS)
Philanthropy
Privacy Policy
Tax policy
ESG Ratings and Honors
Product
Leading Products
Products List
ADR Reporting
R&D
R&D Platforms
Livzon microspheres
Livzon Bio
Livzon Research Institute
R&D Achievements
IP Achievements
Overseas Market
Overseas Business
Specialty Products
Certificates
Contact us
Join Us
Social Recruitment
Campus Recruitment
Compensation and Benefits
Appeal Against
Bidding procurement
Tender Announcement
Supplier Login
Supervision and Reporting
Contact information
Online message
Labor System
New Lijuzhu Magazine
Lizhu first won the "Golden Bauhinia"
On November 23, Lijun Pharmaceutical Group (000513.SZ, 1513.HK) was awarded the "Most Growth-Oriented Listed Company" at the China Securities Golden Bauhinia Awards. This is the first time the company has won an award in the Hong Kong capital market since it was listed on the Hong Kong main board in January 2014. The sixth "China Securities Golden Bauhinia Awards" presented a total of 11 categories of awards, including "Most Influential Listed Company Leader," "Best Listed Company CEO," "Most Investment Value Listed Company Award," and "Most Growth-Oriented Listed Company Award." As one of the most authoritative selection activities for listed companies in the Chinese capital market,
2016-11-21
Why the capital market is so fond of Lijuzhu
As everyone knows, the Chinese capital securities market over the past year has been both thrilling and vast; it has staged legends of eagles soaring in the sky and the disillusionment of high-altitude dives; there have been strong alliances as well as fierce competitions, with some celebrating and others lamenting. It truly is a scene of crashing waves and unpredictable tides, making one's heart race and leaving one at a loss. Only the Livzon Group, standing at the forefront amidst such turbulent waves and sifting sands, steers the ship of Livzon, a vessel with A+H dual listings, navigating the vast sea of pharmaceuticals, cutting through the waves and bravely moving forward. Why can Livzon rise to the challenge? If one must say there is a reason...
2016-08-22
Innovation should be put into practice, and you have done it!
"Innovation should be implemented in this way. We are pleased to see that Lizhu has done a great job in innovation in recent years: the original research new drug Esomeprazole has won the National Science and Technology Progress Second Prize, which is remarkable! You have also taken the lead in the industry in transforming into biomedicine, which is another concrete manifestation of innovation. Especially since you have engaged in the forefront of precision medicine technology, this spirit of innovation is inspiring!" Yesterday morning, Deputy Director Deng Xiaoming of the Ministry of Science and Technology's Social Development Department gave a thumbs up to Lizhu during his research visit! The conversation was lively. Deputy Director Deng couldn't wait to see the industry's most advanced intelligent elevated warehouse, hormone freeze-drying production line, and monoclonal antibodies.
2016-07-22
Lizhu Synthetic Environmental Impact Assessment Second Public Announcement
Lizhu Synthetic Environmental Impact Assessment Second Public Announcement 1. Overview of the Construction Project With the rapid development of the national economy and the domestic pharmaceutical industry, the market demand for gastrointestinal drug series, antipsychotic series, and cardiovascular raw materials has also been rapidly increasing. In order to meet the needs of the industry and the company's development, and to satisfy market demand, Zhuhai Free Trade Zone Lizhu Synthetic Pharmaceutical Co., Ltd. plans to utilize the existing factory buildings and production equipment for technological upgrades and transformations, expanding the variety and output of products. After the transformation, the production scale of cephalosporin products will increase from 730t/a to 950t/a, and the production scale of non-cephalosporin products will increase from 100.3t/a to 420t/a.
2016-07-11
The delegation led by Chang Dongli from Pengzhou City, Sichuan Province visited Lizhu Industrial Park for inspection.
On July 7, Deputy Secretary of the Pengzhou Municipal Committee of Sichuan Province and Mayor Dong Li led a delegation of more than ten people, including Vice Mayor Mao Gaolin, to visit the Lizhu Industrial Park, accompanied by Liu Ran, General Manager of Sichuan Guangda. Tao Desheng, President of Lizhu Group, Zhou Peng, Deputy Secretary of the Group's Party Committee and Assistant to the President, and Xu Xiao, Director of Lizhu Pharmaceutical Factory, warmly welcomed Mayor Dong's delegation. In the newly completed exhibition hall of the Lizhu Industrial Park, Tao Desheng introduced the development status of Lizhu over the past 31 years and details of Lizhu's involvement in the world's most advanced precision medicine field to Mayor Dong and his team. Mayor Dong expressed high appreciation for Lizhu's vision at the forefront of medical technology. Mayor Dong was also in high spirits.
2016-07-08
Lizhu Group is committed to brand building in the food and pharmaceutical industry.
2016-06-03
Lizhu Synthetic Environmental Impact Assessment First Public Announcement
Li Zhu Synthetic Environmental Impact Assessment First Public Announcement 1. Project Overview Li Zhu Synthetic Pharmaceutical Co., Ltd. is located at No. 2 Lianfeng Road, Zhuhai Free Trade Zone, Guangdong Province (currently within the factory area of Li Zhu Synthetic Pharmaceutical Co., Ltd.), covering a total area of 100,000 square meters. In order to enhance the company's market competitiveness and meet the future market demand for non-cephalosporin products, this project will utilize the existing factory buildings to update and upgrade the equipment for the existing non-cephalosporin production line and the cephalosporin production line, as well as upgrade the wastewater treatment system and corresponding pollution prevention facilities. After the renovation, the maximum production capacity of non-cephalosporin products is expected to be 420t/a, cephalosporin.
2016-06-01
The influence of the LIZHU brand has won acclaim.
On April 22, the Zhuhai Federation of Industry and Commerce held an exchange meeting with the Jilin Federation of Industry and Commerce at the Zhuhai Federation of Industry and Commerce building. As a star enterprise that has grown locally in Zhuhai, Lijuzhu Group was invited to attend the meeting. Editor-in-Chief Liu Xibin of New Lijuzhu attended the meeting and delivered a speech on "Four Advantages Continuously Refreshing the Lijuzhu Brand Influence." Yang Hongmei, Vice Chairman of the Zhuhai Federation of Industry and Commerce and Zhuhai General Chamber of Commerce, Jiang Chunhong, Deputy Minister of the Jinwan United Front Work Department and Secretary of the Federation of Industry and Commerce Party Group, Huang Jinye, Vice Chairman of the Xiangzhou District Federation of Industry and Commerce, and nearly 30 guests and friends from the visiting Jilin Federation of Industry and Commerce attended the meeting for exchange. Editor-in-Chief Liu first represented the enterprises of Zhuhai and Lijuzhu Group.
2016-04-25